Castle Biosciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CSTL and other ETFs, options, and stocks.

About CSTL

Castle Biosciences, Inc. is a molecular diagnostics company, which offers innovative test solutions to aid clinicians in the diagnosis and treatment of dermatologic cancers, barrett’s esophagus, uveal melanoma, and in the treatment of mental health conditions. The firm offers DecisionDx-Melanoma, a proprietary multi-gene expression profile (GEP) test that predicts the risk of metastasis and recurrence for patients diagnosed with invasive cutaneous melanoma. 

CEO
Derek J. Maetzold
CEODerek J. Maetzold
Employees
883
Employees883
Headquarters
Friendswood, Texas
HeadquartersFriendswood, Texas
Founded
2007
Founded2007
Employees
883
Employees883

CSTL Key Statistics

Market cap
749.76M
Market cap749.76M
Price-Earnings ratio
-57.53
Price-Earnings ratio-57.53
Dividend yield
Dividend yield
Average volume
469.19K
Average volume469.19K
High today
High today
Low today
Low today
Open price
$23.94
Open price$23.94
Volume
0.00
Volume0.00
52 Week high
$44.28
52 Week high$44.28
52 Week low
$14.59
52 Week low$14.59

Stock Snapshot

Castle Biosciences(CSTL) stock is priced at $24.71, giving the company a market capitalization of 749.76M. It carries a P/E multiple of -57.53.

During the trading day, Castle Biosciences(CSTL) stock saw an opening price of $23.94, a peak of —, and a bottom of —.

Trading activity shows a volume of 0, compared to an average daily volume of 469.19K.

Over the past 52 weeks, Castle Biosciences(CSTL) stock has traded between a high of $44.28 and a low of $14.59.

Over the past 52 weeks, Castle Biosciences(CSTL) stock has traded between a high of $44.28 and a low of $14.59.

CSTL News

Investing.com 7d
Castle Biosciences’ melanoma test outperforms risk tool - Investing.com

...

Castle Biosciences’ melanoma test outperforms risk tool - Investing.com
TipRanks 7d
Castle Biosciences’ i31-SLNB outperforms MIA nomogram in lymph node biopsy

Castle Biosciences (CSTL) announced the publication of a prospective, multicenter study in Dermatology and Therapy demonstrating that DecisionDx-Melanoma’s inte...

Analyst ratings

100%

of 9 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own CSTL. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.